Literature DB >> 17625721

Self-reported adverse reactions among patients initiating antiretroviral therapy in Brazil.

Cristiane A Menezes de Pádua1, Cibele C César, Palmira F Bonolo, Francisco A Acurcio, Mark Drew C Guimarães.   

Abstract

A cross-sectional analysis was carried out to describe adverse reactions to antiretroviral therapy (ART) reported by HIV-infected patients initiating treatment at two public health AIDS referral centers in Belo Horizonte, Brazil, 2001-2003 and to verify their association with selected variables. Adverse reactions were obtained through interview at the first follow-up visit (first month) after the antiretroviral prescription. Socio-demographic and behavioral variables related to ART were obtained from baseline and follow-up interviews and clinical variables from medical charts. Patients with four or more reactions were compared to those with less than four. Odds ratio with 95% confidence interval were estimated using logistic regression model for both univariate and multivariate analyses. At least one adverse reaction was reported by 92.2% of the participants while 56.2% reported four or more different reactions. Antiretroviral regimens including indinavir/ritonavir, irregular use of antiretrovirals and switch in regimens were independently associated with four or more adverse reactions (OR=7.92, 5.73 and 2.03, respectively). The initial period of ARV treatment is crucial and patients' perception of adverse reactions should be carefully taken into account. Strategies for monitoring and management of adverse reactions including the choice of regimens and the prevention of irregular ART should be developed in AIDS/HIV referral centers in Brazil to promote better adherence to antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625721     DOI: 10.1590/s1413-86702007000100007

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  15 in total

1.  Drug metabolism and transport gene polymorphisms and efavirenz adverse effects in Brazilian HIV-positive individuals.

Authors:  Tailah Bernardo de Almeida; Marcelo Costa Velho Mendes de Azevedo; Jorge Francisco da Cunha Pinto; Fernando Rafael de Almeida Ferry; Guilherme Almeida Rosa da Silva; Izana Junqueira de Castro; Paxton Baker; Amilcar Tanuri; David W Haas; Cynthia C Cardoso
Journal:  J Antimicrob Chemother       Date:  2018-09-01       Impact factor: 5.790

2.  Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.

Authors:  Carina Cesar; Bryan E Shepherd; Alejandro J Krolewiecki; Valeria I Fink; Mauro Schechter; Suely H Tuboi; Marcelo Wolff; Jean W Pape; Paul Leger; Denis Padgett; Juan Sierra Madero; Eduardo Gotuzzo; Omar Sued; Catherine C McGowan; Daniel R Masys; Pedro E Cahn
Journal:  PLoS One       Date:  2010-06-01       Impact factor: 3.240

3.  Analysis of self-reported adverse reactions to efavirenz and drug interactions in a population with HIV in Mexico.

Authors:  María Fernanda Martínez-Salazar; Jesús Oaxaca-Navarro; Alfonso Leija-Salas; Sara García-Jiménez; Miguel Angel Sánchez-Alemán; Myrna Déciga-Campos
Journal:  Eur J Hosp Pharm       Date:  2017-03-16

4.  Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals.

Authors:  Camila de Almeida Velozo; Tailah Bernardo de Almeida; Marcelo Costa Velho Mendes de Azevedo; Isabela Espasandin; Jorge Francisco da Cunha Pinto; Sheila López; Luciana Pizzatti; Amilcar Tanuri; Sabrina da Silva Santos; Marcelo Ribeiro-Alves; Cynthia Chester Cardoso
Journal:  Pharmacogenomics J       Date:  2021-09-09       Impact factor: 3.550

5.  Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study.

Authors:  Wondmagegn Tamiru Tadesse; Alemayehu Berhane Mekonnen; Wubshet Hailu Tesfaye; Yidnekachew Tamiru Tadesse
Journal:  BMC Pharmacol Toxicol       Date:  2014-06-23       Impact factor: 2.483

6.  Self-Reported Side Effects and Adherence to Antiretroviral Therapy in HIV-Infected Pregnant Women under Option B+: A Prospective Study.

Authors:  Tamsin Phillips; Annibale Cois; Robert H Remien; Claude A Mellins; James A McIntyre; Greg Petro; Elaine J Abrams; Landon Myer
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

Review 7.  The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis.

Authors:  Haochu Li; Gifty Marley; Wei Ma; Chongyi Wei; Mellanye Lackey; Qingyan Ma; Françoise Renaud; Marco Vitoria; Rachel Beanland; Meg Doherty; Joseph D Tucker
Journal:  AIDS Behav       Date:  2017-02

8.  Treatment outcomes in palliative care: the TOPCare study. A mixed methods phase III randomised controlled trial to assess the effectiveness of a nurse-led palliative care intervention for HIV positive patients on antiretroviral therapy.

Authors:  Keira Lowther; Victoria Simms; Lucy Selman; Lorraine Sherr; Liz Gwyther; Hellen Kariuki; Aabid Ahmed; Zipporah Ali; Rachel Jenkins; Irene J Higginson; Richard Harding
Journal:  BMC Infect Dis       Date:  2012-11-06       Impact factor: 3.090

9.  Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy.

Authors:  Palmira de Fatima Bonolo; Maria das Graças Braga Ceccato; Gustavo Machado Rocha; Francisco de Assis Acúrcio; Lorenza Nogueira Campos; Mark Drew Crosland Guimarães
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

10.  The incidence of first-line antiretroviral treatment changes and related factors among HIV-infected sex workers in Nairobi, Kenya.

Authors:  Frank Ndaks Ndakala; Julius Otieno Oyugi; Margaret Ng'wono Oluka; Joshua Kimani; Georg Martin Norbert Behrens
Journal:  Pan Afr Med J       Date:  2017-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.